A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients
Clinical trial NCT05441553 · UNKNOWN
Trial details
- NCT number
- NCT05441553
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2025-01-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.